The Central Drugs Standard Control Organization(CDSCO) has labelled several medicines as “not of standard quality”. The top drug regulatory authority has flagged 47 batches of medicines for failing quality tests, including eye drops, painkillers, vitamin and even antibiotics. The failed drugs include Abbott India’s gallstones medication Udiliv 300, Mankind Pharma’s iron supplement Ferikind-M Suspension and […]
The diabetic patients in the country have good news which can save their monthly medicine bills. Over 15-20 companies are launching generic versions of the widely-prescribed anti-diabetic drug Vildagliptin, with its price expected to crash by half. The potential of more affordable diabetic care came in the wake of Swiss major Novartis-owned Vildagliptin losing patent […]
Doctors and concerned organizations have called upon the price regulator and the Competition Commission of India to intervene and ward off the apparent monopoly of Dolutegravir- a new HIV drug that received the Indian drug controller’s approval just last month. The drug which is sold by GlaxoSmithKline’s Viiv Healthcare unit is considered to be the […]
The fact that public health is one crucial yet overlooked arena in India is no secret. And if recent trends of policy-making(or the lack thereof) are any indication things are largely gonna remain the same. But what exactly brought about this scenario? The apathy-for that’s what it is, has a cluster of reasons. The World […]
The Indian government has decided to launch a daily drug regimen for treating tuberculosis. This will usurp the existing alternate days schedule. In the initial phase, this is likely to be implemented in five states that include Maharashtra. It’s expected that the launch will happen by September-October of this year.The process is expected to improve […]